78 related articles for article (PubMed ID: 30351207)
1. Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3.
Stansberry WM; Swart M; Medeiros EB; Skaar TC; Pratt VM
Genet Test Mol Biomarkers; 2018 Nov; 22(11):652-655. PubMed ID: 30351207
[TBL] [Abstract][Full Text] [Related]
2. Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.
Visscher H; Ross CJ; Rassekh SR; Sandor GS; Caron HN; van Dalen EC; Kremer LC; van der Pal HJ; Rogers PC; Rieder MJ; Carleton BC; Hayden MR;
Pediatr Blood Cancer; 2013 Aug; 60(8):1375-81. PubMed ID: 23441093
[TBL] [Abstract][Full Text] [Related]
3. Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity.
Magdy T; Jouni M; Kuo HH; Weddle CJ; Lyra-Leite D; Fonoudi H; Romero-Tejeda M; Gharib M; Javed H; Fajardo G; Ross CJD; Carleton BC; Bernstein D; Burridge PW
Circulation; 2022 Jan; 145(4):279-294. PubMed ID: 34874743
[TBL] [Abstract][Full Text] [Related]
4. Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.
Lötsch J; Hofmann WP; Schlecker C; Zeuzem S; Geisslinger G; Ultsch A; Doehring A
Pharmacogenomics; 2011 Dec; 12(12):1729-40. PubMed ID: 22118055
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients.
Vargas-Neri JL; Carleton B; Ross CJ; Medeiros M; Castañeda-Hernández G; Clark P
Pharmacogenomics; 2022 Apr; 23(5):291-301. PubMed ID: 35147047
[No Abstract] [Full Text] [Related]
6. The Role of RARG rs2229774, SLC28A3 rs7853758, and UGT1A6*4 rs17863783 Single-nucleotide Polymorphisms in the Doxorubicin-induced Cardiotoxicity in Solid Childhood Tumors.
Gündüz A; Duman D; Başbinar Y; Taşdelen B; Küpeli S; Karpuz D
J Pediatr Hematol Oncol; 2024 Jan; 46(1):e65-e70. PubMed ID: 37828659
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.
Visscher H; Ross CJ; Rassekh SR; Barhdadi A; Dubé MP; Al-Saloos H; Sandor GS; Caron HN; van Dalen EC; Kremer LC; van der Pal HJ; Brown AM; Rogers PC; Phillips MS; Rieder MJ; Carleton BC; Hayden MR;
J Clin Oncol; 2012 May; 30(13):1422-8. PubMed ID: 21900104
[TBL] [Abstract][Full Text] [Related]
8. Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.
Pratt VM; Beyer BN; Koller DL; Skaar TC; Flockhart DA; Levy KD; Vance GH
J Mol Diagn; 2015 Mar; 17(2):201-5. PubMed ID: 25554586
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3).
Badagnani I; Chan W; Castro RA; Brett CM; Huang CC; Stryke D; Kawamoto M; Johns SJ; Ferrin TE; Carlson EJ; Burchard EG; Giacomini KM
Pharmacogenomics J; 2005; 5(3):157-65. PubMed ID: 15738947
[TBL] [Abstract][Full Text] [Related]
10. Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines.
Hertz DL; Caram MV; Kidwell KM; Thibert JN; Gersch C; Seewald NJ; Smerage J; Rubenfire M; Henry NL; Cooney KA; Leja M; Griggs JJ; Rae JM
Pharmacogenomics; 2016 Feb; 17(3):231-40. PubMed ID: 26799497
[TBL] [Abstract][Full Text] [Related]
11. Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotype.
Lee SJ; Bell DA; Coulter SJ; Ghanayem B; Goldstein JA
J Pharmacol Exp Ther; 2005 Apr; 313(1):302-9. PubMed ID: 15634941
[TBL] [Abstract][Full Text] [Related]
12. Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C.
Doehring A; Hofmann WP; Schlecker C; Zeuzem S; Sarrazin C; Berg T; Müller T; Herrmann E; Geisslinger G; Lötsch J
Pharmacogenet Genomics; 2011 May; 21(5):289-96. PubMed ID: 21346688
[TBL] [Abstract][Full Text] [Related]
13. CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.
Wang X; Sun CL; Quiñones-Lombraña A; Singh P; Landier W; Hageman L; Mather M; Rotter JI; Taylor KD; Chen YD; Armenian SH; Winick N; Ginsberg JP; Neglia JP; Oeffinger KC; Castellino SM; Dreyer ZE; Hudson MM; Robison LL; Blanco JG; Bhatia S
J Clin Oncol; 2016 Mar; 34(8):863-70. PubMed ID: 26811534
[TBL] [Abstract][Full Text] [Related]
14. Specificity of genetic diversity in D1S80 revealed by SNP-VNTR haplotyping.
Limborska SA; Khrunin AV; Flegontova OV; Tasitz VA; Verbenko DA
Ann Hum Biol; 2011 Sep; 38(5):564-9. PubMed ID: 21834750
[TBL] [Abstract][Full Text] [Related]
15. SLC28A3 rs7853758 as a new biomarker of tacrolimus elimination and new-onset hypertension in Chinese liver transplantation patients.
Liu Y; Zhang T; Li C; Ye L; Gu H; Zhong L; Sun H; Sun Y; Peng Z; Fan J
Biomark Med; 2017 Aug; 11(8):607-618. PubMed ID: 28621555
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic mutations in TULP1 responsible for retinitis pigmentosa identified in consanguineous familial cases.
Ullah I; Kabir F; Iqbal M; Gottsch CB; Naeem MA; Assir MZ; Khan SN; Akram J; Riazuddin S; Ayyagari R; Hejtmancik JF; Riazuddin SA
Mol Vis; 2016; 22():797-815. PubMed ID: 27440997
[TBL] [Abstract][Full Text] [Related]
17. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
Daka A; Dimovski A; Kapedanovska A; Vavlukis M; Eftimov A; Labachevski N; Jakjovski K; Geshkovska MN; Nebija D; Mladenovska K
Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
[TBL] [Abstract][Full Text] [Related]
18. [A related analysis for alpha, beta fibrinogen gene haplotypes and nucleotide polymorphisms associated with the ischemic stroke in Hainan Han population].
Liang L; Sun C; Liao XP; Xiao F; Chen XD; Huang SX; Tang XL; Wen GQ; Long ZG; Wang XY; Liu GX; Cheng S; Cai WW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):316-9. PubMed ID: 16767673
[TBL] [Abstract][Full Text] [Related]
19. Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection.
Rau M; Stickel F; Russmann S; Manser CN; Becker PP; Weisskopf M; Schmitt J; Dill MT; Dufour JF; Moradpour D; Semela D; Müllhaupt B; Geier A;
J Hepatol; 2013 Apr; 58(4):669-75. PubMed ID: 23195617
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.
Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M
Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
